{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:06:45Z","timestamp":1792098405067,"version":"4.4.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1093\/brain\/awf087","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T18:48:15Z","timestamp":1027709295000},"page":"812-822","source":"Crossref","is-referenced-by-count":202,"title":["Contrast\u2010enhanced MRI in acute optic neuritis: relationship to visual performance"],"prefix":"10.1093","volume":"125","author":[{"given":"Mark J.","family":"Kupersmith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Alban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Zeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lefton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2002,4]]},"reference":[{"key":"key\n\t\t\t\t20170624045919_AWF087C1","doi-asserted-by":"crossref","unstructured":"Barnes D, McDonald WI, Landon DN, Johnson G. The characterization of experimental gliosis by quantitative nuclear magnetic resonance imaging. Brain1988; 111: 83\u201394.","DOI":"10.1093\/brain\/111.1.83"},{"key":"key\n\t\t\t\t20170624045919_AWF087C2","doi-asserted-by":"crossref","unstructured":"Barnes  D, Munro PM, Youl BD, Prineas JW, McDonald WI. The longstanding MS lesion. A quantitative MRI and electron microscopic study.  Brain1991;114: 1271\u201380.","DOI":"10.1093\/brain\/114.3.1271"},{"key":"key\n\t\t\t\t20170624045919_AWF087C3","doi-asserted-by":"crossref","unstructured":"Beck  RW, Cleary PA, Anderson MM, Keltner JL, Schults WT, Kaufman DI, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med1992; 326: 581\u20138.","DOI":"10.1056\/NEJM199202273260901"},{"key":"key\n\t\t\t\t20170624045919_AWF087C4","doi-asserted-by":"crossref","unstructured":"Beck  RW, Cleary PA, Backlund JC. The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial.  Ophthalmology1994; 101: 1771\u20138.","DOI":"10.1016\/S0161-6420(94)31103-1"},{"key":"key\n\t\t\t\t20170624045919_AWF087C5","doi-asserted-by":"crossref","unstructured":"Beck  RW, Cleary PA, Trobe JD, Kaufman DI, Kupersmith MJ, Paty DW, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.  N Engl J Med1993; 329: 1764\u20139.","DOI":"10.1056\/NEJM199312093292403"},{"key":"key\n\t\t\t\t20170624045919_AWF087C6","doi-asserted-by":"crossref","unstructured":"Dunker  S, Wiegand W. Prognostic value of magnetic resonance imaging in monosymptomatic optic neuritis. Ophthalmology1996; 103: 1768\u201373.","DOI":"10.1016\/S0161-6420(96)30429-6"},{"key":"key\n\t\t\t\t20170624045919_AWF087C7","unstructured":"Fisher  LD, van Belle G. Biostatistics. A methodology for the health sciences. New York: John Wiley; 1993. p. 138\u2013450"},{"key":"key\n\t\t\t\t20170624045919_AWF087C8","doi-asserted-by":"crossref","unstructured":"Gass A, Barker GJ, MacManus D, Sanders M, Riordan\u2010Eva P, Tofts PS, et al. High resolution magnetic resonance imaging of the anterior visual pathway in patients with optic neuropathies using fast spin echo and phased array local coils. J Neurol Neurosurg Psychiatry1995; 58: 562\u20139.","DOI":"10.1136\/jnnp.58.5.562"},{"key":"key\n\t\t\t\t20170624045919_AWF087C9","doi-asserted-by":"crossref","unstructured":"Guy J, Mancuso A, Beck R, Moster ML, Sedwick LA, Quisling RG, et al. Radiation\u2010induced optic neuropathy: a magnetic resonance imaging study.  J Neurosurg1991; 74: 426\u201332.","DOI":"10.3171\/jns.1991.74.3.0426"},{"key":"key\n\t\t\t\t20170624045919_AWF087C10","doi-asserted-by":"crossref","unstructured":"Guy  J, Mao J, Bidgood D, Mancuso A, Quisling RG. Enhancement and demyelination of the intraorbital optic nerve. Fat suppression magnetic resonance imaging. Ophthalmology1992; 99: 713\u201319.","DOI":"10.1016\/S0161-6420(92)31892-5"},{"key":"key\n\t\t\t\t20170624045919_AWF087C11","doi-asserted-by":"crossref","unstructured":"Hendrix  LE, Kneeland JB, Haughton VM, Daniels DL, Szumowski J, Williams AL, et al. MR imaging of optic nerve lesions: value of gadopentetate demeglumine and fat\u2010suppression technique. AJNR Am J Neuroradiol1990; 11: 749\u201354.","DOI":"10.2214\/ajr.155.4.2119121"},{"key":"key\n\t\t\t\t20170624045919_AWF087C12","doi-asserted-by":"crossref","unstructured":"Iwasawa  T, Matoba H, Ogi A, Kurihara H, Saito K, Yoshida T, et al. Diffusion\u2010weighted imaging of the human optic nerve: a new approach to evaluate optic neuritis in multiple sclerosis. Magn Reson Med1997; 38: 484\u201391.","DOI":"10.1002\/mrm.1910380317"},{"key":"key\n\t\t\t\t20170624045919_AWF087C13","doi-asserted-by":"crossref","unstructured":"Jacobs  LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, et al. Intramuscular interferon beta\u20101a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med2000; 343: 898\u2013904","DOI":"10.1056\/NEJM200009283431301"},{"key":"key\n\t\t\t\t20170624045919_AWF087C14","doi-asserted-by":"crossref","unstructured":"Kapoor  R, Miller DH, Jones SJ, Plant GT, Brusa A, Gass A, et al. Effects of intravenous methylprednisolone on outcome in MRI\u2010based prognostic subgroups in acute optic neuritis. Neurology1998; 50: 230\u20137.","DOI":"10.1212\/WNL.50.1.230"},{"key":"key\n\t\t\t\t20170624045919_AWF087C15","doi-asserted-by":"crossref","unstructured":"Katz  D, Taubenberger JK, Cannella B, McFarlin DE, Raine CS, McFarland HF. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol1993; 34: 661\u20139.","DOI":"10.1002\/ana.410340507"},{"key":"key\n\t\t\t\t20170624045919_AWF087C16","doi-asserted-by":"crossref","unstructured":"Keltner  JL, Johnson CA, Spurr JO, Beck RW. Visual field profile of optic neuritis. One\u2010year follow\u2010up in the Optic Neuritis Treatment Trial. Arch Ophthalmol1994; 112: 946\u201353.","DOI":"10.1001\/archopht.1994.01090190094027"},{"key":"key\n\t\t\t\t20170624045919_AWF087C17","doi-asserted-by":"crossref","unstructured":"Kermode  AG, Thompson AJ, Tofts P, McManus DG, Kendall BE, Kingsley DP, et al. Breakdown of the blood\u2013brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain1990; 133: 1477\u201389.","DOI":"10.1093\/brain\/113.5.1477"},{"key":"key\n\t\t\t\t20170624045919_AWF087C18","doi-asserted-by":"crossref","unstructured":"Lee  DH, Simon JH, Szumowski J, Feasby TE, Karlik SJ, Fox AJ, Pelz DM. Optic neuritis and orbital lesions: lipid\u2010suppressed chemical shift MR imaging. Radiology 1991; 179: 543\u20136.","DOI":"10.1148\/radiology.179.2.2014308"},{"key":"key\n\t\t\t\t20170624045919_AWF087C20","doi-asserted-by":"crossref","unstructured":"Miller  DH, Newton MR, van der Poel JC, du Boulay EP, Halliday AM, Kendall BE, et al. Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology1988; 38: 175\u20139.","DOI":"10.1212\/WNL.38.2.175"},{"key":"key\n\t\t\t\t20170624045919_AWF087C21","doi-asserted-by":"crossref","unstructured":"Optic Neuritis Study Group. The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol1991; 109: 1673\u20138.","DOI":"10.1001\/archopht.1991.01080120057025"},{"key":"key\n\t\t\t\t20170624045919_AWF087C22","unstructured":"Sartoretti\u2010Schefer S, Wichman W, Valvanis A. Optic neuritis: characteristic magnetic resonance imaging features and differential diagnosis. Int J Neuroradiol1997; 3: 417\u201327."},{"key":"key\n\t\t\t\t20170624045919_AWF087C23","unstructured":"Sklar  EM, Schatz NJ, Glaser JS, Post JD, ten Hove M. MR of vasculitis\u2010induced optic neuropathy. AJNR Am J Neuroradiol1996; 17: 121\u20138."},{"key":"key\n\t\t\t\t20170624045919_AWF087C24","doi-asserted-by":"crossref","unstructured":"Stewart  WA, Alvord ECr, Hruby S, Hall LD, Paty DW. Magnetic resonance imaging of experimental allergic encephalomyelitis in primates. Brain1991; 114: 1069\u201396.","DOI":"10.1093\/brain\/114.2.1069"},{"key":"key\n\t\t\t\t20170624045919_AWF087C25","doi-asserted-by":"crossref","unstructured":"Swartz  NG, Beck RW, Savino PJ, Sergott RC, Bosley TM, Lam BL, et al. Pain in anterior ischemic optic neuropathy. J Neuroophthalmol1995; 15: 9\u201310.","DOI":"10.1097\/00041327-199503000-00002"},{"key":"key\n\t\t\t\t20170624045919_AWF087C26","doi-asserted-by":"crossref","unstructured":"Tien  RD, Hesselink JR, Szumowski J. MR fat suppression combined with Gd\u2010DTPA enhancement in optic neuritis and perineuritis. J Comput Assist Tomogr1991; 15: 223\u20137.","DOI":"10.1097\/00004728-199103000-00006"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/125\/4\/812\/17864732\/1250812.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T15:26:42Z","timestamp":1503415602000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awf087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2002,4]]},"published-print":{"date-parts":[[2002,4]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awf087","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}